NovoCure (NASDAQ: NVCR) published its first set of quarterly results for 2025, and they pleased more than a few investors. For the first quarter, NovoCure recorded net revenue that was just shy of ...

On Friday, the People’s Bank of China (PBOC) set the USD/CNY central rate for the trading session ahead at 7.2066 as compared ...